Advanced MRI biomarkers for efficient clinical trial designs in Progressive Supranuclear Palsy (PSP)
The integration of advanced MRI processing techniques, including volumetric and dMRI analyses, enhances sensitivity to brain changes in PSP, significantly reducing sample size requirements for clinical trials. These findings underscore the importance of selecting robust imaging biomarkers and analysis methods to improve trial efficiency and accelerate therapeutic development for PSP.
Authors
- Jean‐Philippe Coutu
- Alex Zijdenbos
- Simone P. Zehntner
- Felix Carbonell
- Barry J Bedell
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_102985
- Primary Topic
- Advanced Neuroimaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00